INTRODUCTION
An emerging theme in the study of innate immune signal transduction is the importance of subcellular localization for protein function. Observations in support of this claim were first made through the study of the Toll-like receptors (TLRs), which can be found at the plasma membrane as well as on various endosomal organelles (Barton and Kagan, 2009) . Recently, this principle has been extended to the cytosolic signaling proteins that act downstream from TLRs (Kagan and Medzhitov, 2006; Kagan et al., 2008; Rowe et al., 2006) . It is at this level that the first mechanistic insight has come to explain the link between subcellular localization and protein function. For example, TLR4 activates two signaling pathways that are dictated by the localization of the TIR domain-containing adaptor pairs, TIRAP-MyD88 and TRAM-TRIF (Barton and Kagan, 2009) . Signaling induced by the TIRAP-MyD88 pair occurs from the cell surface and mediates the expression of inflammatory cytokines by a process dependent on NF-kB and AP-1 (Horng et al., 2002 ; Kagan and Medzhitov, 2006; Yamamoto et al., 2002) . TIRAP contains a lipid-binding domain that permits its localization to phosphatidylinositol 4,5-bisphosphate (PIP2)-rich regions of the plasma membrane (Kagan and Medzhitov, 2006) . By binding these PIP2-rich regions of the cell surface, TIRAP is positioned to recruit, or ''sort,'' MyD88 to this location in order to promote signaling. Whereas MyD88 interacts directly with the downstream enzyme IRAK4 to induce signal transduction, TIRAP cannot. Thus, TIRAP is considered a sorting adaptor, whose primary function is to deliver the signaling adaptor MyD88 to plasma membrane-localized TLRs (Barton and Kagan, 2009 ). Similar cell biological rules can be applied to the other TIR-containing adaptor pair, TRAM-TRIF. This adaptor pair mediates the expression of type I interferons (IFNs) from endosomes after microbe-induced endocytosis of TLR4 by a process dependent on IRF3 (Doyle et al., 2002; Kagan et al., 2008; Tanimura et al., 2008) . TRAM contains a bipartite localization motif consisting of a phosphoinositide-binding domain and a myristoylation motif, which permits its delivery to the plasma membrane and endosomes (Kagan et al., 2008; Rowe et al., 2006) . It is from this latter location that TRAM engages activated TLR4 and induces the recruitment of TRIF (Kagan et al., 2008; Tanimura et al., 2008) . Like MyD88, TRIF is a bona fide signaling adaptor in that it interacts directly with downstream signaling enzymes, such as the E3 ubiquitin ligases TRAF3 and TRAF6 (Hä cker et al., 2006; Sato et al., 2003) . TRAM cannot directly bind to these factors. Thus, like TIRAP, TRAM is considered a sorting adaptor, whose function is to recruit TRIF to endosome-localized TLR4 to promote signal transduction.
Although the sorting-signaling adaptor paradigm has emerged as an important regulatory process in mammalian innate immunity, its significance in lower eukaryotes is less clear. The reason for this confusion is that no known homologs of the sorting adaptors exist in lower eukaryotes. For example, Drosophila melanogaster has long been the model organism of choice to study evolutionary aspects of innate immunity (Hoffmann, 2003) , but neither TIRAP nor TRAM have been identified in flies. Despite the lack of identified sorting adaptors in flies, Drosophila Toll, like several mammalian TLRs, requires two adaptor molecules to link it to the downstream kinases of the IRAK/Pelle family Sun et al., 2004) . Because Drosophila Toll requires two adaptor proteins, we considered the possibility that one of these might serve a sorting adaptor function. The receptor proximal adaptor shows substantial sequence homology to the mammalian MyD88 protein and thus was named dMyD88 (or dmMyD88) (Horng and Medzhitov, 2001; Tauszig-Delamasure et al., 2002) . The other adaptor, Tube, has no known mammalian homolog. Interestingly, biochemical analysis indicates that the interactions that the conserved adaptor MyD88 undergoes during signal transduction differ between mammals and flies. For example, in mammals, MyD88 binds directly to IRAK family members (Lin et al., 2010; Motshwene et al., 2009 ), but in flies, dMyD88 cannot bind directly to the IRAK homolog Pelle . Rather, Tube serves this function with dMyD88 only binding indirectly to Pelle .
Because the known sorting adaptors are not found in lower eukaryotes, the question remains as to whether the subcellular positioning of adaptors is only important for Toll signaling in mammals. Considering that sorting adaptors bind indirectly to signaling enzymes in mammals, as well as the fact that the known adaptor protein Tube lies between dMyD88 and Pelle , we considered the possibility that MyD88 may have different functions in mammals and flies. We hypothesized that unlike its mammalian namesake, dMyD88 may function analogously to TIRAP by serving the role of a sorting adaptor in Drosophila Toll signaling. Herein, we show that dMyD88 contains a C-terminal phosphoinositide-binding motif that directs it to the plasma membrane. Moreover, we demonstrate the functional importance of this localization domain in vivo and establish that signaling is at least initiated from the plasma membrane by dMyD88's ability to recruit downstream signaling components to the cell surface. We propose that the use of sorting-signaling adaptor pairs in Toll signaling predates mammals and that the cell biological principles that govern innate signaling pathways represent a fundamental rule throughout evolution.
RESULTS
dMyD88 Is Localized to the Plasma Membrane A defining feature of mammalian sorting adaptors is their ability to localize to regions of the cell that contain TLRs even before signaling has been initiated (Barton and Kagan, 2009; Kagan and Medzhitov, 2006; Kagan et al., 2008) . This function is thought to facilitate rapid detection of activated receptors and promote the recruitment of downstream adaptors to these sites. dMyD88 has been found at the plasma membrane in Drosophila embryos (Sun et al., 2004) , but whether this localization was simply the result of developmental Toll signaling in vivo is unknown. To address the intrinsic presignaling localization of dMyD88, we examined the subcellular distribution of this adaptor in Drosophila S2 cells. In fly cells, dMyD88 was localized to the plasma membrane ( Figure 1A and Figure S1 available online). Similarly, dMyD88 was found to be enriched at plasma membrane ruffles in primary mouse macrophages ( Figure 1B ), suggesting that dMyD88 does not require any fly-specific factors for its plasma membrane recruitment. Similar results were obtained when examining the localization of TIRAP ( Figure 1B) , whereas mouse MyD88 (mMyD88) was found in foci scattered throughout the cell ( Figure 1B) . The fact that dMyD88 localization appeared similar to that of TIRAP prompted us to investigate whether these two proteins were recruited to similar regions of the plasma membrane. To address this question, we examined the distribution of dMyD88 and TIRAP within the same cell. dMyD88 and TIRAP were both concentrated at overlapping regions of membrane ruffles in wild-type (WT) mouse macrophages ( Figure 1C ), raising the possibility that these adaptors utilize a similar mechanism of protein localization. Collectively, these data indicate that dMyD88 resides at the plasma membrane and that recruitment of dMyD88 to the cell surface does not require a fly-specific factor.
dMyD88 Is a Phosphoinositide-Interacting Protein Sequence homology had originally identified dMyD88 as the Drosophila homolog of mammalian MyD88 (Horng and Medzhitov, 2001; Tauszig-Delamasure et al., 2002) . Both proteins contain an N-terminal death domain and a TIR domain. However, unlike its mammalian counterpart, dMyD88 contains a C-terminal extension (CTE) that does not have similarity to any known protein domains. We hypothesized that this CTE was responsible for dMyD88 localization to the plasma membrane. To test this hypothesis, we generated deletion mutants and examined the resulting proteins for their ability to phenocopy the localization of full-length dMyD88. Consistent with our hypothesis, the CTE was sufficient to phenocopy full-length dMyD88 localization ( Figure 2A ). In contrast, dMyD88 mutants lacking the C-terminal domain (DD + TIR) were cytosolic ( Figure 2A ). These results provide evidence that membrane localization of dMyD88 occurs independently of its signaling domains. Thus, dMyD88 exhibits a property common to other sorting adaptors, given that both TIRAP and TRAM use TIR-independent means of membrane localization (Kagan and Medzhitov, 2006; Kagan et al., 2008; Rowe et al., 2006) .
Examination of the localization motif of dMyD88 revealed that this region had a higher isoelectric point than the rest of the protein (10.16 and 6.71, respectively). The localization domains of TIRAP and TRAM also possess this characteristic, which is a feature found in domains that bind phospholipids (McLaughlin et al., 2002) . Because both TIRAP and TRAM are phosphoinositide-interacting proteins (Kagan and Medzhitov, 2006; Kagan et al., 2008) , we performed in vitro protein-lipid interaction assays to assess the ability of dMyD88 to bind to membrane lipids. More specifically, we used PIP strips and PIP arrays, which are commercially available nitrocellulose membranes that contain a variety of lipid species ( Figures 2B and S2 ). Glutathione S-transferase (GST)-tagged dMyD88, but not mouse MyD88, bound detectably to all the negatively charged phosphoinositides ( Figure 2B ). This interaction with phosphoinositides was specific, given that dMyD88 did not interact with unphosphorylated phosphatidylinositol or any of the general membrane lipid species examined, such as phosphatidylethanolamine, phosphatidylcholine, or phosphatidylserine (Figure 2B) . Consistent with our hypothesis that the C-terminal localization domain is responsible for this interaction, the CTE of dMyD88 bound the same phosphoinositides as the full-length protein ( Figure 2B ). In contrast, the N-terminal portion of dMyD88 (DD + TIR) was defective for lipid binding in vitro ( Figure 2B ). As an independent approach, we examined the ability of GST-dMyD88 to bind liposomes containing either PI(4)P, PI(4,5)P2 or PA. GST-dMyD88 interacted preferentially with liposomes containing PI(4,5)P2 and to a lesser extent liposomes containing PI(4)P ( Figure 2C ). Similar results were obtained when the CTE was used in this pull-down assay (data not shown). Taken together, these data indicate that dMyD88 is a phosphoinositide-interacting protein and that the CTE, which is responsible for its localization, is also responsible for this interaction.
The C-terminal Phosphoinositide-Binding Domain of dMyD88 Is Necessary to Control Infections in Flies It is very common for phosphoinositide-binding proteins to exhibit promiscuous binding in vitro, but a single lipid usually mediates protein localization in vivo (Lemmon, 2003) . To deter- (B) Fluorescence micrographs of primary mouse macrophages transfected with dMyD88-YFP, FLAG-TIRAP, or FLAG-mMyD88. Cells were costained with FLAG antibodies and Alexa Fluor-647 phalloidin so that F-actin could be visualized. As evidenced by the costaining with F-actin in the merged images, dMyD88 and TIRAP both localize to membrane ruffles. (C) Fluorescence micrographs of primary mouse macrophages expressing TIRAP-GFP and FLAG-dMyD88. Note that both TIRAP and dMyD88 are concentrated in overlapping regions of membrane ruffles. All images are representative of at least three independent experiments where over 500 cells were examined per condition and >95% of the cells displayed similar staining. Scale bars represent 5 mm. See also Figure S1 . mine which lipid species is probably mediating dMyD88 localization within cells, we generated a series of chimeric alleles in which the natural lipid-binding domain was replaced with domains that interact with single phosphoinositides. We focused specifically on lipids that are found to some extent at the plasma membrane because this is the natural site of dMyD88 residence. In S2 cells, chimeric dMyD88 proteins that bind specifically to PI(4)P through the attachment of the pleckstrin homology (PH) domain of FAPP1 did not phenocopy the localization of the WT allele ( Figure S3A ). In addition, neither the PI(3,4,5)P3 specific domains (PH domain of GRP1) nor the PI(3)P-specific domain (PX domain of Gp91phox) exhibited a localization similar to WT dMyD88 ( Figure S3A ). In contrast, the dMyD88 chimera containing a PI(4,5)P2 (PIP2)-specific PH domain from PLCd1 (dMyD88-PLC) phenocopied the localization of the WT protein (Figures 3 and S3A ). The PLCd1 PH domain was chosen for our studies because it is one of the only known domains that interact specifically with PIP2 in vitro and in vivo (Lemmon, 2003) . This specificity is due to its unusually high affinity for this lipid. Thus, the fact that dMyD88-PLC phenocopied the localization of WT dMyd88 made PIP2 a likely candidate for the in vivo regulator of dMyD88 localization. To determine whether PIP2 binding by dMyD88 is sufficient for its signaling functions, we reconstituted dMyD88 mutant flies with the dMyD88-PLC allele. We also reconstituted dMyD88 mutant flies with the full-length dMyD88 allele (dMyD88-FL) or an allele lacking its localization domain (dMy88-Cyto). The collection of these transgenic lines permits the side-by-side examination of the functional consequence of altering the affinity of dMyD88 for phosphoinositides, in particular PIP2. All transgenic fly lines produced comparable amounts of dMyD88 RNA and their respective dMyD88 proteins ( Figures 3C and 3D ), and the alleles used for generating these lines displayed the expected subcellular distributions in S2 cells ( Figure 3B ).
Because dMyD88 mutant flies are highly susceptible to infection by Gram-positive bacteria (Kambris et al., 2003; TauszigDelamasure et al., 2002) , the transgenic lines were tested for their ability to rescue this immune phenotype. None of the parental lines showed a difference in survival after E. faecalis infection, suggesting that any variation between the dMyD88 mutant flies complemented with the dMyD88 transgenes reflect the expression of the various dMyD88 alleles and not the insertion of the transgenes ( Figure S3B ). As expected, infection by either E. faecalis or S. epidermidis caused rapid and complete lethality of dMyD88 mutant flies, and this phenotype was complemented by the expression of full-length dMyD88 (Figures 3E and 3F) . In contrast, flies expressing the cytosolic allele (dMyD88-Cyto) displayed reduced resistance to infection (Figures 3E and 3F) . These results indicate that plasma membrane localization is necessary for the immune functions of dMyD88. Interestingly, dMyD88-PLC flies survived even better than their dMyD88-FL counterparts (Figures 3E and 3F) , suggesting that PIP2 binding by dMyD88 is sufficient for the immune functions of this adaptor. The possibility that the PLCd1 PH domain has any intrinsic signaling functions was ruled out when we assayed were incubated with GST-tagged full-length dMyD88, mouse MyD88 (mMyD88), and the dMyD88 deletion mutants described in (A). dMyD88 and its CTE interact with all PIs tested, whereas mMyD88 and the N-terminus (DD+TIR) do not.
(C) Quantitative analysis of dMyD88's ability to bind liposomes containing 18% of the indicated phosphoinositide. Shown is a representative experiment (n = 6) demonstrating that dMyD88 interacts preferentially to PIP2 when compared to other phospholipids. See also Figure S2 .
its ability to rescue Toll signaling in dMyD88-deficient S2 cells. Unlike the cells expressing dMyD88-FL and dMyD88-PLC, no significant Drosomycin expression was observed in cells expressing the PLCd1 PH domain alone (Figure S3C ). To confirm that non-Toll immune pathways were unaffected by the dMyD88 transgenes, infections were performed with the Gram-negative bacteria E.coli, which is eradicated by the Imd pathway (Leulier et al., 2000) . None of the transgenic lines were sensitive to infection by E. coli ( Figure 3G ), whereas the Imd pathway mutant kenny succumbed to infection by this bacteria. To confirm that the observed survival defect in dMyD88-Cyto flies resulted from reduced Toll signaling, we measured the expression of antimicrobial peptides (AMP) known to be induced following activation of the Toll pathway (De Gregorio et al., 2002) . Consistent with a defect in Toll signaling, dMyD88 mutant flies expressing dMyD88-Cyto displayed decreased expression of both Drosomycin (Drs) and Metchnikowen (Mtk) in response to infection with either E. faecalis or S. epidermidis ( Figures 4A and 4B) . However, induction of Diptericin (Dpt), an AMP induced by the Imd pathway, was not affected ( Figure S4 ). Interestingly, dMyD88-PLC displayed higher expression of Toll-activated AMPs both at baseline and after infection. This observation probably explains the heightened resistance to bacterial infection exhibited by flies expressing this transgene.
We hypothesized that the differences in survival after infections may result from an inability to kill and clear the bacteria. To address this possibility, we challenged male flies with E. faecalis and homogenized individual flies to measure their bacterial loads. Consistent with the survival defect, dMyD88-Cyto flies were unable to control the infection, as a higher bacterial load was observed in these mutant flies when compared to flies that readily control the infection (FL or PLC counterparts) ( Figure 4C ). However, as compared to flies that display dMyD88 at the plasma membrane (FL or PLC), the bacterial load in dMyD88-Cyto flies varied greatly from fly to fly with some flies having bacterial loads as high as the null mutants and others having bacterial loads as low as dMyD88-FL flies. These results suggest that a diffusion-mediated process of dMyD88 recruitment results in an unreliable antimicrobial response, which probably explains the decreased ability of dMyD88-Cyto flies to survive bacterial infections. Collectively, these data indicate that membrane localization is necessary for maximal Toll signaling in Drosophila, and that the C-terminal phosphoinositide binding domain of dMyD88 is both necessary and sufficient for dMyD88 localization and antimicrobial functions. (C) Individual male flies of the indicated genotype were injected with E. faecalis and homogenized 0.5 or 8 hr after infection. Serial dilutions of the homogenized flies were plated on kanamycin-containing agar plates to determine bacterial loads. Due to large variances, the data in (C) was log transformed for statistical analysis. *p < 0.05, **p < 0.01, Student's t test. See also Figure S4 .
Immunity dMyD88 Is a Sorting Adaptor et al., 2002). This need for maternal deposition of the dMyD88
transcript renders homozygous dMyD88 mutant females sterile (Charatsi et al., 2003; Kambris et al., 2002) . Thus, to test whether PIP2 binding by dMyD88 is necessary for development, we tested homozygous dMyD88 mutant flies expressing the various transgenes for their ability to rescue the sterility phenotype observed in dMyD88 homozygous females. Consistent with our finding that plasma membrane localization is necessary for the function of dMyD88, females expressing the cytosolic allele (dMyD88-Cyto) failed to produce viable progeny ( Figure 5 ). In contrast, both the full-length and the PLC alleles restored female fertility ( Figure 5 ). Taken together, these data indicate that plasma membrane localization of dMyD88 is necessary for its developmental function.
dMyD88 Functions to Recruit Tube to the Plasma Membrane Until recently, it was assumed that Toll signaling occurred at the plasma membrane. Our data fully support this idea and suggest that PIP2-rich regions of the plasma membrane are the preferred site of Toll signaling. However, recent reports claim that Toll signaling occurs from an endocytic compartment (Huang et al., 2010; Lund et al., 2010) . We reasoned that if dMyD88 is indeed functioning as a sorting adaptor, then it must recruit a signaling adaptor to the site of signaling. Given the genetic and biochemical data placing the adaptor Tube downstream of dMyD88 Sun et al., 2004) , we hypothesized that Tube would serve the role of the signaling adaptor. To address this prediction, we first needed to know where in the cell Tube resides. Expressing Tube in S2 cells revealed that Tube is found to be evenly distributed throughout the cytosol ( Figure 6A ). Given that Tube localization differed from dMyD88, we next examined whether dMyD88 was capable of recruiting Tube to the plasma membrane in a signaling domain dependent manner. To address this question, we coexpressed Tube with full-length dMyD88 or a dMyD88 mutant lacking the death domain. Under both conditions, dMyD88 localized to the plasma membrane, further validating that its localization is independent of its signaling domains. Tube, on the other hand, was no longer observed to be cytosolic when coexpressed with full-length dMyD88. Rather, Tube colocalized with full-length dMyD88 at the plasma membrane ( Figure 6B ). This colocalization was not observed when Tube was expressed with the dMyD88 mutant lacking the death domain, indicating that a signaling domain is necessary for the observed cell surface recruitment ( Figure 6B ). Collectively, our results, along with previous in vivo data showing dMyD88-dependent Tube localization at the plasma membrane (Sun et al., 2004) , suggest that signaling is at least initiated at the plasma membrane and that the subcellular localization of dMyD88 prepositions this adaptor to recruit downstream signaling proteins.
The C-terminal Extension Is Conserved throughout Invertebrate Evolution
To determine whether the properties of dMyD88 represent a common theme in the invertebrate lineage, we analyzed the MyD88 gene from other insect species for the presence of a CTE. All insect species analyzed had a CTE connected to the TIR domain of their MyD88 gene ( Figure S5 ). Interestingly, none of these invertebrate species had a TIRAP homolog (Figure S5) . In contrast to what we observed in the insect lineage, among the vertebrate species that we analyzed, none had a MyD88 allele with additional sequence after the TIR domain, but all had a TIRAP homolog ( Figure S5 ). The strong correlation between the presence of the CTE and the absence of a TIRAP homolog supports our hypothesis that this localization domain endows MyD88 with sorting adaptor function. To further test this hypothesis, we cloned the MyD88 gene from a clinically relevant insect species and determined its localization. Specifically, we expressed the MyD88 homolog from Anopheles gambiae (AgMyD) in S2 cells and found that AgMyD localizes to the plasma membrane ( Figure 7A ). Because AgMyD localized to the cell surface, we were prompted to investigate whether its distribution overlapped with dMyD88 localization. When coexpressed within the same cell, AgMyD colocalized with dMyD88 at the plasma membrane ( Figure 7B ). These results suggest that localization of MyD88 to the plasma membrane is a fundamental principle of insect Toll signaling.
DISCUSSION

Research performed on the innate immune responses of
Drosophila has undoubtedly contributed to our current knowledge of the mammalian TLR network. However, in an interesting twist of events, we now have a more advanced understanding of the cell biology of TLR signaling in mammals than the ancestral Toll pathway in flies. For example, it has become increasingly clear that the mammalian TLRs and their adaptors depend on basic cell biological trafficking factors for their subcellular localization and signaling functions. Whether the cell biological ''rules'' that govern TLR signaling in mammals applies to lower eukaryotes is unknown. A potential explanation for this gap in our knowledge is that the known mammalian adaptors that exhibit interesting cell biological properties, such as the sorting adaptors TIRAP and TRAM, are not found in flies. Although there are no obvious homologs for these sorting adaptors, the receptor proximal complex found in flies displays notable symmetry to the receptor proximal complex found in mammals. For example, both the mammalian and fly pathways rely on two adaptor proteins to bridge the activated receptor to downstream kinases. From this comparison, we considered the idea that the fly adaptors serve equivalent roles to the mammalian sorting-signaling adaptor pair. In particular, we hypothesized that dMyD88 functions as a sorting adaptor. In all cell biological assays performed, dMyD88 does not behave as its mammalian namesake, but rather phenocopies the sorting adaptor TIRAP. Like TIRAP, dMyD88 is localized to the plasma membrane at steady state in the absence of Toll signaling, and this plasma membrane localization is mediated by a C-terminal phosphoinositide-binding domain. Moreover, just as TIRAP can recruit MyD88 to the plasma membrane by a process dependent on its signaling domain (Kagan and Medzhitov, 2006) , dMyD88 can recruit the downstream adaptor Tube to the plasma membrane by a similar process. Taken together, our cell biological and genetic analyses suggest that dMyD88 is functionally a sorting adaptor. Although the idea that protein localization is important for adaptor function has attracted much attention, the importance of this localization in preventing infections in vivo has remained unclear. Our findings that transgenic flies containing dMyD88-Cyto exhibit defects in AMP expression, control of bacterial replication, and ultimately survival demonstrate the fundamental importance of sorting adaptor localization for immune defense Figure 6 . dMyD88 Recruits Tube to the Plasma Membrane (A) S2 cells were transfected with FLAG-Tube and stained with FLAG antibodies. (B) S2 cells were cotransfected with either full-length dMyD88 (YFP-FL) or a dMyD88 mutant lacking the death domain (YFP-DDD) and Tube. The dMyD88 vectors were under the control of the metallothionein promoter; thus, for inducing expression of these constructs, 500 mM CuSO 4 was added to the cells 6 hr after transfection. Forty-eight hours after CuSO 4 induction, Tube is redistributed to the cell surface with full-length dMyD88, but not the DDD mutant. All images are representative of at least three independent experiments in which >500 cells were examined per condition and >95% of the cells displayed similar staining. Scale bars represent 5 mm.
in vivo. Moreover, our additional finding that dMyD88-PLC can complement the immune defects of dMyD88 mutant flies suggests that the only activity needed within the C-terminal localization domain is the ability to bind PIP2. Thus, we propose that PIP2 in the primary mediator of dMyD88 localization in flies.
Because PIP2 is enriched at the plasma membrane, our suggestion that this lipid is the primary mediator of dMyD88 localization implies that Toll signaling occurs at the cell surface. Recently, however, this idea has been contested by reports indicating that endocytosis is necessary for the proper activation of the Toll pathway (Huang et al., 2010; Lund et al., 2010) . From its comparison to mammalian TLRs that activate signal transduction after receptor internalization, the discovery that endocytosis is necessary for the Drosophila Toll pathway suggests an evolutionarily conserved role for endocytosis in Toll signaling. Although this parallel is intriguing, there are important differences between these two pathways that indicate that endocytosis does not play similar roles in flies and mammals. One notable difference is that the mammalian TLRs require endocytosis to activate a second signaling pathway that is induced uniquely from endosomes (Kagan et al., 2008; Tanimura et al., 2008) . For example, in the best-characterized mammalian system, TLR4 first signals from the plasma membrane to activate NF-kB, and then later switches to the IRF3 activating pathway that is induced from endosomes. The Drosophila Toll pathway, on the other hand, is not known to induce distinct signaling pathways. Rather, flies activate a single dMyD88-Tubedependent pathway that results in AMP expression (TauszigDelamasure et al., 2002) . Although endocytosis may be involved in this Drosophila pathway, our results suggest that Toll signaling is at least initiated at the plasma membrane. We provide several lines of evidence to support this idea. First, dMyD88 recruits Tube to the plasma membrane. This recruitment only occurs in a signal-dependent manner because dMyD88 mutants lacking the death domain are incapable of delivering Tube to the cell surface. Second, dMyD88-PLC rescues the immune phenotype observed in dMyD88 mutants. As stated above, the PH domain of PLCd1 binds to PIP2, which is highly enriched at the cell surface and virtually absent from endosomes. In fact, during endocytosis, PIP2 concentrations fall so drastically (Botelho et al., 2000) that it is unlikely that dMyD88-PLC would be present at very high quantities on early endosomes, and thus, unlikely that Toll signaling would be initiated from this internal cellular location in these flies. Furthermore, the fact that dMyD88-PLC signals better even at baseline provides further credence to the hypothesis that signaling must occur at the plasma membrane, given that this result implies that dMyD88 localization to the cell surface is a rate-limiting step in the Toll signaling pathway. Collectively, our data suggest that the initial site of Toll signaling is from the plasma membrane, but subsequent endocytic events may extend the duration of the signaling response.
It is intriguing, though, that dMyD88-PLC does signal better than the WT adaptor. As described above, the PH domain from PLCd1 is an excellent tool to study the sufficiency of PIP2 binding by dMyD88, because it is one of the only known domains that binds PIP2 with high affinity in vitro and in vivo (Lemmon, 2003) . If an interaction domain works better to protect against infection, then why did nature choose to use the weaker PIP2 binding domain for dMyD88? One hypothesis is that the weaker PIP2 interacting domain may be evolutionarily advantageous for Toll signaling in flies. For example, it is possible that endocytosis is required for Toll signaling and that the adaptor complex must be released from the membrane either for downregulation or continuation of the signal. It is also possible that the weaker PIP2 binding domain evolved to avoid constitutively high amounts of AMP production, which have been shown to be deleterious to the animal. For example, chronic activation of the Imd pathway leads to altered commensal populations and reduced lifespan (Libert et al., 2006; Ryu et al., 2008) . Although Toll signaling has not be implicated in the regulation of commensal bacteria, it is possible that such strong baseline signaling as observed with dMyD88-PLC may affect the fly's interaction with its commensal microbiota and, thus, may lead to death by allowing noxious bacterial species to dominate the gut.
In addition to its function in innate immunity, Toll signaling is important for development in Drosophila. The protein weckle is the only cytosolic factor thus far identified that is selectively required for Toll signaling in development, and it has been proposed to function by recruiting dMyD88 to the plasma membrane to engage Toll (Chen et al., 2006) . Our data demonstrating that dMyD88 must encode a plasma membrane localization motif for its signaling functions in development suggest that any interactions between weckle and dMyD88 are not sufficient for plasma membrane recruitment and signaling. It is therefore possible that weckle acts at a different stage of Toll signaling, perhaps downstream of the sorting-signaling adaptors dMyD88 and Tube.
Although this study has focused on the role that dMyD88 plays in Toll signaling, our results also highlight the functional significance of Tube. On the basis of the sorting-signaling adaptor paradigm established in mammalian cells, our data indicate that Tube is the functional equivalent of mammalian MyD88. Classifying Tube as a signaling adaptor strengthens the analogy to the mammalian system, but it raises the question of why there is a need for these sorting-signaling pairs in flies. In the mammalian network, not all TLRs use the same adaptors (Akira and Takeda, 2004) . For example, many plasma membrane-localized TLRs utilize both TIRAP and MyD88, whereas only MyD88 is needed for signaling by TLRs found on endosomes. The fact that MyD88 is needed in both subcellular compartments suggests that sorting adaptors, like TIRAP, evolved to recruit MyD88 to the proper signaling location. On the basis of this evolutionary perspective, we speculate that the need for dMyD88 evolved because Tube functions in additional locations within the cell. Eight other Tolls have been identified in flies (Tauszig et al., 2000) , but few (if any) play a role in immunity. It is possible that the other Tolls are needed for various immune responses not yet characterized, and that these immune responses occur in a different cellular location than at the plasma membrane. Thus, based on the analogy to the mammalian system, dMyD88 would have evolved to bring the signaling adaptor Tube to the plasma membrane, whereas other sorting adaptors may be required to recruit Tube to other signaling locations. Further characterization of other Tolls and their dependence on the known adaptor molecules is needed to address this possibility.
EXPERIMENTAL PROCEDURES
Cell Culture, Transfections, and Immunofluorescence S2 cells were maintained at 25 C in Schneider's Drosophila medium (GIBCO) supplemented with 10% FBS and 1% penicillin and streptomycin. Cells were transfected with 1 mg of expression vector with Fugene 6 in accordance to the manufacturer's protocol (Roche). Forty-eight hours after transfection, cells were washed in serum-free media and then incubated on alcian blue coverslips for 30 min prior to fixation. Cells were fixed at 25 C in 2% paraformaldehyde for 20 min, made permeable for 10 min with 1X phosphate buffered saline (PBS) + 0.1% Triton-X, and incubated with block buffer (2% goat serum, 50 mM ammonium chloride in PBS) for 30 min. Samples were then incubated with the appropriate antibodies diluted in block buffer. Antibody binding was detected with AlexaFluor secondary antibodies from Molecular Probes and visualized with a spinning-disk confocal microscope (Zeiss Axiovert 200M).
Images were captured and analyzed with Slidebook 5.0 software (Intelligent Imaging Innovations). Primary bone marrow-derived macrophages from wild-type (C57B6) mice were prepared as previously described (Kagan and Roy, 2002) . Macrophages were transfected by nucleofection (AMAXA) with the mouse macrophage transfection reagent. After transfection, the cells were plated on coverslips and incubated at 37 C for 4 hr prior to fixing. Staining of macrophages was performed as described above for S2 cells, except that AlexaFluor 647-phalloidin (Molecular Probes) was included with the secondary antibody to identify F-actin.
Protein Purification and Lipid Binding Assays
GST-fusion proteins were purified from BL21 E. coli using glutathione Sepharose 4B (Amersham) in accordance to the manufacturer's instructions. Purity of each GST preparation was confirmed by SDS-PAGE and Coomassie staining. PIP strips and PIP arrays were performed as previously described (Kagan and Medzhitov, 2006) . Quantitative lipid pull-down assays were performed as previously described (Kagan and Medzhitov, 2006) , except that 10 mg of each GST protein were mixed with 50 mg of liposomes containing 18% of the indicated phosphoinositide. Fluorescence recovered by beads coated with GST-mMyD88 was subtracted from each sample to account for nonspecific binding of liposomes to the beads.
Fly Strains and Crosses
All flies were maintained at 25 C on a standard cornmeal medium. The mutant strains used in this study (PBc03881 and key) have been previously described (Kambris et al., 2003; Rutschmann et al., 2000) . Transgenic flies were generated by P-element transformation of w1118 embryos with standard procedures (Rainbow Transgenic Flies, Inc.). Constructs used for generating transgenic flies were created by cloning dMyD88-FL (nucleotides 1-1614) and dMyD88-Cyto (nucleotides 1-1158) into pUAST (Brand and Perrimon, 1993) . For the dMyD88-PLC chimera, the N-terminal sequence (nucleotides 1-1158) was fused to the PH domain of PLCd1 by overlap extension PCR and then cloned into pUAST. Each construct was crossed into the dMyD88 homozygous mutant background, along with the hs-Gal4 driver for all infection assays. The genotype of these flies was dMyD88 c03881 , hsGal4/dMyD88 c03881 , and UAS-dMyD88 transgene (for which the transgene is dMyD88-FL, dMyD88-PLC, or dMyD88-Cyto). Because of the known leakiness of the heat-shock promoter (Kambris et al., 2003; Maurange and Paro, 2002) , no heat shock was necessary in order to express the transgenes. The V 32 -Gal4 driver (Maxton-KuchenmeisterMaxton-Kü et al., 1999) was used for obtaining high expression of maternal Gal4 in the sterility assays. At least two independent lines were tested in every experiment for each dMyD88 transgene. Homozygous dMyD88 mutant flies (dMyD88 c03881 /dMyD88 c03881 ) and wild-type dMyD88 heterozygotes (dMyD88 c03881 /CyO) were used as controls.
Infection Experiments
Septic injury was performed by pricking 2-to 4-day-old male flies with a tungsten needle previously dipped in a pellet from an overnight culture of E. faecalis (ATCC number 10100), S.epidermidis (gift from P. Watnik), or E. coli (XL1 Blue). After bacterial infection, flies were immediately transferred to 29 C. Flies that died in the first 3 hr were discarded. Flies were scored daily for survival experiments or RNA was extracted from the infected flies at the indicated times using RNA-Bee (Fisher). RT-PCR was carried out with a Bio-Rad iQ5 real time cycler with Taqman probes as directed by the manufacturer.
Determination of CFU in Flies
Flies were challenged with an overnight culture of E. faecalis as described above and incubated at 29 C for 8 hr. Individual flies were homogenized in 100 ml of PBS, diluted serially, and spread onto Brain Heart Infusion agar plates supplemented with 25 mg/mL of kanamycin. It should be noted that no kanamycin-resistant bacteria grew out of lysates from noninfected flies.
Plasmids pJL1-FLAG-dMyD88, pCMV2-FLAG-dMyD88, pJL1-FLAG-Tube, pCMV2-FLAG-TIRAP, pCMV2-FLAG-mMyD88, and TIRAP-GFP were described previously (Horng and Medzhitov, 2001; Kagan and Medzhitov, 2006) . The pCMV2-FLAG-dMyD88 vector was used as a template for cloning dMyD88 into pEYFP-C1 (Clonetech) and pGEX4T1 (Amersham). The sequences coding for the N-terminal (DD+TIR) construct (nucleotides 1-1158) and the CTE vector (nucleotides 1125-1614) were amplified by PCR with pCMV2-FLAG-dMyD88 as a template and then cloned into either pJL1-FLAG vector (Horng and Medzhitov, 2001) or pGEX4T1. Metallothionine vectors encoding YFP-FL or YFP-DDD (nucleotides 709-1614) were generated by subcloning the YFP-tagged dMyD88 cDNAs from pEYFP-C1 into pJL252 (Horng and Medzhitov, 2001 ). The AgMyD gene was cloned into the pJL1-FLAG vector by amplifying the AgMyD from Anopheles gambiae cDNA with the following forward and reverse primers (F: 5 0 -ATGTTGGATAATCCCGTAAAACC-3 0 ;
R: 5 0 -TTACACAGCGCTAGCTAGTTTTC-3 0 ).
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